The Covid vaccines were designed primarily to prevent severe disease and death -- two purposes for which they continue to work very well.
On December 10, 2020, the Center for Biologics Evaluation and Research’s (CBER), Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet in open session to discuss Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 in individuals 16 years of age and older.
>>The Covid vaccines were designed primarily to prevent severe disease and death -- two purposes for which they continue to work very well.
>On December 10, 2020, the Center for Biologics Evaluation and Research’s (CBER), Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet in open session to discuss Emergency Use Authorization (EUA) of the **Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19** in individuals 16 years of age and older.
(post is archived)